Development of lifestyle intervention program for diabetes using IoT(Internet of Things)

Not Applicable

• Conditions: Diabetes

• Registration Number: JPRN-UMIN000022465
• Lead Sponsor: Aichi Health Promotion Public Interest Foundation

Brief Summary

In the health guidance model, both the IoT and control groups showed a significant HbA1c reduction at 3 months as compared with the baseline, while only the IoT group maintained a significant reduction at 6 months along with BMI decreases. In the hospitalization model, both the IoT and the control groups showed significant HbA1c reductions at 3 and 6 months as compared with the baseline, while there were no differences in the values between groups.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-05-26
• Study Completion: 2017-09-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 181

Inclusion Criteria

Not provided

Exclusion Criteria

Diabetic nephropathy phase 4(eGFR<30ml/min/1.73m2) Receiving insulin therapy Proliferative diabetic retinopathy or preproliferative retinopathy, and prohibited from participating the program by ophthalmologist Under treatment of dementia Under treatment of cancer Under treatment of myocardial infarction and apoplexy Subjects prohibited from participating the program by medical doctors

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HbA1c

Secondary Outcome Measures

Name	Time	Method
Completion rate, utilization of IoT